Lee Howard 4
4 · Amphastar Pharmaceuticals, Inc. · Filed Jun 5, 2023
Insider Transaction Report
Form 4
Lee Howard
Director
Transactions
- Sale
Common Stock
2023-06-01$45.02/sh−16,679$750,960→ 142,939 total - Exercise/Conversion
Stock Option (right to buy)
2023-06-01−16,679→ 0 totalExercise: $16.69Exp: 2026-06-07→ Common Stock (16,679 underlying) - Exercise/Conversion
Common Stock
2023-06-01$16.69/sh+16,679$278,373→ 159,618 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.80 to $45.29, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- [F2]Shares subject to the option are fully vested and immediately exercisable.